ORMP Oramed Pharmaceuticals Inc.
Healthcare$3.98+0.00%OpenMarket Cap: $163.0M
As of 2026-05-26
Insider Statistics (Q1 2026)
Acquisitions
8
Dispositions
8
Buy/Sell Ratio
1.00
Net Shares
-187,727
Shares Acquired
644,341
Shares Disposed
832,068
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Mar 31 | KIDRON NADAV | director, officer: President and CEO | Sell | 44,818 | $3.31 | 3,422,243 |
| Tue Mar 31 | Kidron Miriam | director, officer: Chief Scientific Officer | Sell | 435,084 | $3.31 | 1,133,138 |
| Wed Mar 18 | KIDRON NADAV | director, officer: President and CEO | Sell | 167,005 | $0.00 | 3,422,243 |
| Wed Mar 18 | Kidron Miriam | director, officer: Chief Scientific Officer | Sell | 119,558 | $0.00 | 1,568,222 |
| Wed Mar 18 | Hexter Joshua | officer: COO & CBO | Sell | 95,889 | $0.00 | 1,160,384 |
| Wed Mar 18 | Gabay Avraham | officer: Chief Financial Officer | Sell | 95,889 | $0.00 | 745,145 |
| Mon Mar 16 | KIDRON NADAV | director, officer: President and CEO | Sell | 100,000 | $0.00 | 3,255,238 |
| Thu Jan 29 | Kidron Miriam | director, officer: Chief Scientific Officer | Sell | 19,000 | $0.00 | 1,448,664 |
| Thu Jan 29 | Hexter Joshua | officer: COO & CBO | Sell | 19,000 | $0.00 | 1,064,495 |
| Thu Jan 29 | Gabay Avraham | officer: Chief Financial Officer | Sell | 19,000 | $0.00 | 649,256 |